These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 1466255

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
    Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J.
    J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
    Kobayashi Y, Ochi M, Tokue A.
    Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
    [Abstract] [Full Text] [Related]

  • 7. [Serum levels of carboxyterminal propeptide of type I procollagen (PICP), cross-linked carboxyterminal telopeptide region of type I collagen (ICTP) and carboxyterminal parathyroid hormone-related protein (C-PTHrP) in hematological malignancies with bone lesions and hypercalcemia].
    Tanaka K, Shiraishi K, Sakamoto A, Jojima H, Masuchi K, Okubo Y, Tanaka M, Fuzimatsu Y, Fukahori S, Osabe S, Imamura Y, Honda J, Oizumi K.
    Rinsho Ketsueki; 1998 Apr; 39(4):273-80. PubMed ID: 9597894
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
    Francini G, Gonnelli S, Petrioli R, Bruni S, Marsili S, Aquino A, Camporeale A.
    Cancer Epidemiol Biomarkers Prev; 1993 Apr; 2(2):125-9. PubMed ID: 8467247
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence.
    Edwall L, Carlström K, Jonasson AF.
    Neurourol Urodyn; 2005 Apr; 24(4):319-24. PubMed ID: 15924353
    [Abstract] [Full Text] [Related]

  • 14. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 15. Assessment of the relationship between circadian variations of salivary melatonin levels and type I collagen metabolism in postmenopausal obese women.
    Ostrowska Z, Kos-Kudla B, Marek B, Swietochowska E, Górski J.
    Neuro Endocrinol Lett; 2001 Apr 15; 22(2):121-7. PubMed ID: 11335888
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the relationship between dynamic pattern of nighttime levels of melatonin and chosen biochemical markers of bone metabolism in a rat model of postmenopausal osteoporosis.
    Ostrowska Z, Kos-Kudla B, Swietochowska E, Marek B, Kajdaniuk D, Górski J.
    Neuro Endocrinol Lett; 2001 Apr 15; 22(2):129-36. PubMed ID: 11335889
    [Abstract] [Full Text] [Related]

  • 17. [Serum concentration of pyridinoline cross-linked carboxy-terminal telopeptide of type-I collagen (ICTP) and carboxyterminal propeptide of human type I procollagen (PICP) in the diagnosis of bone metastases].
    Koizumi M, Yamada Y, Takiguchi T, Suzuki C, Akashi T, Nomura E, Yamashita T, Ogata E.
    Kaku Igaku; 1996 Jan 15; 33(1):77-84. PubMed ID: 8819718
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Type I collagen and procollagen fragments in patients with metabolic bone diseases.
    Lin JS, Kao JT, Tsai KS.
    J Formos Med Assoc; 1996 Jul 15; 95(7):523-9. PubMed ID: 8840753
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of the carboxy-terminal propeptide of type I procollagen and the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen as markers of bone metastases in patients with prostate carcinoma.
    Hosoya Y, Arai K, Honda M, Sumi S, Yoshida K.
    Eur Urol; 1997 Jul 15; 31(2):220-3. PubMed ID: 9076470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.